|
|
|
| Comparative
Mouse Genomics Center
|
U01
ES11045
|
| Principle
Investigator: |
W.C.
Ladiges
|
| Funding
Agency: |
|
| Dates
of Funding |
04/01/01-03/31/07
|
|
One
of five centers across the U.S. collaborating
to develop mouse models for studying the
biological function of environmentally
sensitive DNA repair/cell cycle control
gene variants in the human population,
and establishing a genetically engineered
mouse system as a mammalian model for
human functional genomics and single nucleotide
polymorphism variant-environment interactions.
|
|
|
Nathan
Shock Center of Excellence in Basic Biology
of Aging
|
P30
AG13280
|
| Principle
Investigator: |
P.S. Rabinovitch
|
| Funding
Agency: |
NIH
/ National Institute on Aging
|
| Core
PI: |
|
W. C. Ladiges
|
| Dates
of Funding: |
07/01/05
- 06/30/10
|
|
Ladiges
is director of Resource Core A, a program
for transgenic animal model development
providing state-of-the-art technology
for the development of genetically altered
rodents in order to advance knowledge
about the basic biology of aging.
|
|
| Center
for Ecogenetics and Environmental Health |
P30 ES07033
|
| Principle
Investigator: |
D.
Eaton
|
| Core
PI: |
W.C.
Ladiges
|
| Funding
Agency: |
|
|
| Dates
of Funding: |
04/01/05
– 03/31/10
|
|
Ladiges
is director of Resource Core 4, a program
providing transgenic animal support for
the development of new rodent models evaluating
gene action in response to environmental
influences.
|
|
| Gene
Action in the Pathobiology of Aging |
P30
AG01751
|
| Principle
Investigator: |
P.S.
Rabinovitch
|
| Core
PI: |
W.C.
Ladiges
|
| Funding
Agency: |
|
|
| Dates
of Funding: |
10/01/03
– 09/30/08
|
|
This
program project aims to provide a vehicle
for a highly integrated series of investigations
designed to test theories of aging that
emphasize a major role for oxidative damage
to DNA, especially mitochondrial DNA,
and with an emphasis on the use of genetically
altered mice.
|
|
|
Genetic
Instability in Werner Syndrome |
P01
CA77852
|
|
Principle
Investigator: |
R.
J. Monnat
|
| Core
PI: |
Ladiges
|
| Funding
Agency: |
|
|
|
Funding
Dates: |
07/01/04
– 06/30/09
|
|
Ladiges
is leader of Core B, a resource designed
to provide animal breeding, maintenance,
and phenotyping resources for program
research projects and cores with a focus
on the WRN gene, genomic instability, and tumorigeneis.
|
|
| The
FHCRC/UW Toxicogenomics Consortium |
U19
ES11387
|
| Principle
Investigator: |
Zarbl
|
| Funding
Agency: |
NIH/National
Institute of Environmental Health Sciences
|
| Dates
of Funding: |
|
10/01/01-09/30/06
|
|
The
overall aim is to describe global gene
expression profiles for wild-type and
transgenic mice and rats and human cell
lines exposed to a variety of environmentally-relevant
xenobiotics.
|
|
|
DNA
replication fidelity and cancer |
R01
CA098243
|
|
Principle
Investigator: |
B. Preston
|
| Co-Investigator: |
W.C.
Ladiges
|
| Funding
Agency: |
|
|
| Funding
Dates: |
04/01/04-03/30/09
|
|
The
overall goal of this project is to characterize
the role of DNA polymerase delta proof-reading
in the maintenance of genetic stability
and avoidance of disease. The specific
aims are to characterize the mutator phenotype
of pol delta exo minus cells and mice,
and to examine cooperativity of pol delta
with mismatch repair.
|
|
|
Regulating Longevity
|
|
| Principle
Investigator: |
Kennedy and Rabinovitch
|
| Core
PI: |
W.C. Ladiges
|
| Funding
Agency: |
|
Ellison Medical Foundation
|
| Dates
of Funding: |
01/01/05 -
12/31/09
|
|
A consortium for the determination
of public pathways regulating longevity
This consortium will establish an exceptional infrastructure for research
into the genetic regulation of aging: a systematic library of yeast
strains, worm models and mouse strains and associated databases that will
be available to all aging researchers. These will represent a unique
resource for study of the genetic elements and pathways whose
down-regulation may extend lifespan and health span.
|
|
| Alzheimer’s disease and
impaired APP proteolysis |
R21 AG26476
|
| Principle
Investigator: |
W.C. Ladiges
|
| Co-Investigator:
|
J.C. Wiley
|
| Funding
Agency: |
|
NIH
/ NIA
|
| Dates
of Funding: |
09/01/05 - 08/31/07
|
|
Alzheimer’s disease and impaired
APP proteolysis
The goal of this proposal is to study the effects of familial Alzheimer’s
disease mutations on the gamma-secretase mediated cleavage of APP in the
brains of mice using a transgenic reporter mouse model.
|
|
|
|
Copyright
© 2004 University of Washington. All rights reserved
Tuesday July 19, 2005 10:25 AM
|
|
|
|
|